Online life science pharma marketplace and platform for products and services.

 

Current location: Home » Events » Conferences and meetings » Content

2nd Annual Personalised Medicines & Cancer Biomarkers 2016

Zoom in  Zoom out Publish date: 2016-07-22   Hits: 0   Status: Status
Date 2016-10-12 to 2016-10-13
City London, UK
Address Pestana Chelsea Bridge Hotel
Exhibition hall Pestana Chelsea Bridge Hotel
Sponsor 2nd Annual Personalised Medicines & Cancer Biomarkers
Undertaker

Event Description
 Strategies & Developments in Personalised Medicines & Cancer Biomarkers

Conference Information:

 

Personalized Medicine (PM) is a developing routine of medication that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, determination, and treatment of ailment. Information of a patient's hereditary profile can offer specialists some assistance with selecting the best possible prescription or treatment and manage it utilizing the correct measurement or regimen. PM guarantees more effective prevention and prediction of diseases, and earlier and safer treatment. It will change our approach to public health and the way we care for patients in the future. However, in order to successfully implement PM all stakeholders, including patients and healthcare professionals, need to be empowered and aware of its potential. In modern societies, health care systems are increasingly difficult to navigate and education systems too often fail to provide people with adequate skills to access, understand, assess and use information to improve their health. We need to improve knowledge and understanding of PM, encourage public engagement, and provide evidence that PM will benefit patients and society.

 

The global cancer biomarkers market has experienced substantial growth over the last couple of years. This market is expected to grow at a CAGR of 11.6% from 2015 to 2020. Factors such as rising incidence of cancer; technological advancements in omics technologies; favorable government funding for cancer research; increased demand for personalized medicines in cancer therapies; and increased use of biomarkers in drug discovery development and clinical trials are expected to fuel the growth of the cancer biomarkers market during the forecast period. However, poorly suited regulatory and reimbursement systems of biomarker tests, high capital investments for biomarker discovery and development, and sample collection and storage difficulties are restraining the growth of this market.

 

At this conference, you will benefit from the expert knowledge of leaders into omics and disease research who are currently working towards a future where medical interventions are more precise, more targeted and are resulting in better patient outcomes. You will hear from those that are currently discovering and developing therapies, with companion diagnostics, and from the professionals who are responsible for personalised medical products and cancer biomarkers that have already hit the market. There will also be discussions involving industry and regulatory bodies on the improvements and challenges of personalised medicine and its practical impact on the future of healthcare.

 

It gives us immense pleasure in welcoming you to "2nd Annual Personalised Medicines & Cancer Biomarkers 2016"

 

 

 

 

Key Speakers:

 

*            

               JAYA GOYAL, Director, Translational Sciences, Value-Based Medicine, Biogen (USA)

              

*            

               DARREN HODGSON, Senior Principal Translational Scientist, Oncology iMED, AstraZeneca

              

*            

               JORG MAHLICH, Health Economist, Janssen, Pharmaceutical Companies of Johnson and Johnson

              

*            

               SUMIT MUNJAL, Medical Director, Takeda Pharmaceuticals

              

*            

               PHILLIP EICHORN, Senior Director (Worldwide Safety and Regulatory), Pfizer

              

*            

               MICHAEL MERZ, Chair investigative Liver Expert Team, Novartis

              

*            

               MOHAMMAD AFSHAR, CEO, Ariana Pharma

              

*            

               OMAR ALI, Visiting Lecturer Value Based Pricing & Innovative Contracting & Member, University of Portsmouth, NICE Adoption & Impact Programme Reference Panel

              

*            

               MARIA HERNANDEZ FUENTES, Senior Lecturer in Translational Research, King's College London

              

*            

               LINCOLN TSANG, Partner, Arnold & Porter

              

*            

               JOHN WISE, Executive Director Business Development, Pistoia Alliance

              

*            

               HANS LEHRACH, Vertebrate Genomics, Max Planck Institute for Molecular Genetics

              

*            

               MOHAMED OUBIHI, Founder and Managing Director, YAKUMED

              

*            

               STEPHEN R PENNINGTON, Professor of Proteomics, University College Dublin

              

*            

               MARIA ISABEL MANLEY, Partner, Head of the Regulatory Practice, Bristows

              

 

 

 

Key Themes

 

*            

               Personalised Medicine and Cancer Biomarkers – Market analysis and the way forward

              

*            

               The Impact of Precision Medicine on the future of healthcare

              

*            

               Personalised Medicine and Cancer Biomarkers in the USA,EU

              

*            

               Use of biomarkers for decision-making in cancer therapy

              

*            

               Impact of multiplexed genotyping in directing cancer care

              

*            

               Biomarker discovery & validation - Government policies & strategies

              

*            

               Changing the business model to integrate personalised medicine

              

*            

               Learn about the latest findings in genomics and how to apply them to your practice

              

*            

               The role of artificial intelligence in precision medicine

              

*            

               Development and application of clinical safety biomarkers with a focus on imaging biomarkers

              

*            

               The development and application of cancer biomarkers as clinical tests.

              

*            

               Discuss how to disseminate genomic information to patients through ethical, legal and regulatory frameworks

              

*            

               Companion diagnostics & Personalised medicine

              

*            

               Impact of technology & Point of Care

              

*            

               Leverage big data to generate real world evidence (RWE) on biomarkers' clinical and economic utility

              

*            

               Predictive and prognostic cancer biomarkers for immuno-oncology

              

*            

               Design strategies for success in early phase trials

              

*            

               Analyze biomarkers and their role in drug development

              

*            

               Assess preclinical safety considerations

              

*            

               Emerging stratified medicine via successful partnerships

              

*            

               Network in our combined exhibition and catering area

              

*            

               Evening networking reception for all attendees

 

Why Should You Sponsor:

 

 

 

Virtue Insight Conferences and events offer commercial organisations and partners a wide range of opportunities to promote their products and services at our events during the calendar year! All of our Virtue Insight sponsorship opportunities are tailored to your requirements and we provide a number of flexible packages that will meet your company’s marketing objectives. Sponsorship can be used in a number of ways to increase your brand and product awareness in both a highly targeted and clutter free environment. Partnering with Virtue Insight allows you to showcase your brand and product in a professional and independent setting, when our delegates are in a receptive and engaging mindset. Our experts will work with you and your team, to create real added value to any campaign and we welcome the opportunity to discuss your requirements in detail. Furthermore, Virtue Insight has a hard earned reputation for forming strong, long standing and valuable partnerships with our sponsors and we will work hard to deliver your campaign, on time and on budget!

 

 

 

Benifits of Sponsorship:

 

*            

               Access a niche, hard to reach, targeted audience within your industry sectors

*            

               Talk to key industry specialists within business, academic and government bodies

*            

               Develops market leadership, through a role that fosters dialogue on key business issues and trends

*            

               Generates prospects and sales, by bringing customers to you

*            

               Provides a respected forum for your ideas on topics that affect your business

*            

               Amplifies your message, by providing a setting of heightened receptiveness

*            

               Provides influence, through face-to-face opportunities to engage in dialogue with thought and decision leaders Advantages

*            

               Provides a practical, well respected avenue to market leadership

*            

               Presents opportunities to form important, new business relationships

*            

               Demonstrate corporate brand values to a wider audience

*            

               Change or enhance Brand perceptions

*            

               Drive Brand ‘Consideration’

*            

               Gain credible Brand Endorsement

*            

               Showcase new Product launches

*            

               Provide a cost effective and focused platform on which to engage your consumers

*            

               Networking; Bringing together buyers and sellers in a independent and intimate environment

*            

               Exposure to international experts; via our conferences, website, email database, Social Media and Newsletters

*            

               Meeting your customers; they could be current, former or even potential customers. Discover what the factors influencing them are and what they think about you and your competitors.

              

 

Who Should Attend:

 

 

Senior attendees from leading Pharmaceutical, Biopharmaceutical, Biotechnology, Diagnostics, Academics, Government, CRO, Hospitals and solution provider companies will be attending. Meet Senior VPs, Directors, and Managers with the following categories:

 

*            

               Pharmaceutical Company Leaders

*            

               Diagnostic/Analytics Company Leaders

*            

               Biotechnology

*            

               CRO

*            

               Medical/Diagnostics Laboratories, Consulting, Biobanks

*            

               Genome Interpretation Experts

*            

               Genome Sequencing Pioneers

*            

               Biotech Leaders

*            

               Healthcare Providers

*            

               Consultants

*            

               Doctors & Pharmacists

*            

               Government Leaders

*            

               Health Insurance Executives

*            

               Investors

*            

               Biomarkers Pharmacogenomics

*            

               Oncology

*            

               Molecular Biology

*            

               Epigenetics

*            

               Clinical Pharmacology Statistical Biomarkers

*            

               Clinical Oncology

*            

               Proteomics

*            

               Discovery Medicine

*            

               Clinical and Translational Research

*            

               Experimental Medicine

*            

               Systems Biology

*            

               CNS

*            

               Toxicity

*            

               Regulation

*            

               PK/PD

*            

               Genomic

*            

               Pharmacogenetics

*            

               Molecular Informatics

*            

               Neurology

*            

               MicroRNA

*            

               Imaging

 

Why Should You Attend:

 

 

2nd Annual Pharma Anti-Counterfeiting & Serialisation 2016 - "Strategies & Developments in Personalised Medicines & Cancer Biomarkers"

 

 

 

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. You cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway.  Devise an immediate action plan for your strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins.

 

 

 

 

Conference Booking Details:

 

Super Early Discount (valid till 12 Aug 16): £ 650 + VAT (Per person)

 

Super Early Discount (valid till 12 Aug 16): £ 1300 + VAT (3 Delegates)

 

 

 

Standard Pricing 1 Delegate: £ 1100 + VAT

 

 

 

You can simply email and book your conference delegate seats

 

Conference Sponsor & Exhibition Space – Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to saket@vipharmaevents.com <mailto:saket@vipharmaevents.com


Contact information
Contact: 2nd Annual Personalised Medic
Tel:
 
[ Events Search ]  [ ]  [ Tell a friend ]  [ Print ]  [ Close

Total 0  Comments

 
Browse by category
 
New Events